reuters dr scott gottlieb president donald trump ’ nominee lead u food drug administration outline measure would take untangle tie pharmaceutical industry confirm senate
ethic disclosure form file department health human service tuesday gottlieb say would resign multiple corporate board include glaxosmithkline plc consulting position
gottlieb ’ financial tie healthcare industry extensive
confirm agree recuse matter financial interest divest holding 20 mostly small healthcare company
gottlieb 44 widely expect confirm though pharmaceutical tie likely scrutinize democrat
past decade partner new enterprise associate large venture capital fund investment life science
would also resign position investment firm tr
winston co say would perform consult work run agency participate matter involve previous client year last providing service client
gottlieb resident fellow conservative american enterprise institute think tank view favorably drug industry
would responsible implement key element recently pass 21st century cure act call agency streamline drug approval process